FKBP5 and Uterine leiomyoma: Whirledge et al found that dexamethasone (DEX) increased FKBP5 levels, reduced the number of cells in S-phase, and inhibited the expression of the estrogen receptor along with genes regulating cell replication in immortalized human uterine leiomyoma cells (4).